您的位置: 首页 > 农业专利 > 详情页

ANTI-TNF-ALPHA THERAPY FOR THE MUCOPOLYSACCHARIDOSES AND OTHER LYSOSOMAL DISORDERS
专利权人:
Gary E. Striker;Calogera M. Simonaro;Helen Vlassara;Edward H. Schuchman
发明人:
Edward H. Schuchman,Calogera M. Simonaro,Gary E. Striker,Helen Vlassara
申请号:
US14128411
公开号:
US20140205584A1
申请日:
2012.06.20
申请国别(地区):
US
年份:
2014
代理人:
摘要:
The present invention relates to methods of treating a subject with a lysosomal disorder, by administering an agent for enzyme replacement therapy and an agent for anti-TNF-α therapy; by administering a pentosan polysulfate therapy; or by administering a substrate reduction therapy and an anti-TNF-α therapy. The invention further relates to a method of reducing inflammatory cytokines in a subject with a lysosomal disorder that is being treated by enzyme replacement therapy, by administering an agent for anti-TNF-α therapy.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充